CO₂ is commonly associated with environmental concerns, but this molecule harbors intriguing potential to be employed as a sustainable carbon source. With appropriate catalytic systems, CO₂ can be converted to high-value products like fuels, fine chemicals, and pharmaceuticals. Our focus is to use carbon dioxide and to create energetically challenging C-C bonds to produce fine chemicals and pharmaceuticals such as aliphatic carboxylic acids. We have projects related to catalyst design, asymmetric synthesis and radiopharmaceutical synthesis. As part of the CHOCO group and the NordCO2 consortium we tightly combine experimental and computational studies in our work.

Related publications:
♦  Chem. Eur. J. 2020, 6064.Formal C-H carboxylation of unactivated arenes with carbon dioxide. doi: 10.1002/chem.202000515.
♦  ChemSusChem, 2020, 2080. Exploration of New Biomass-Derived Solvents: Application to Carboxylation Reactions. Open access! doi:10.1002/cssc.201903224.
♦  Organometallics 2018, 941. Rhodium-Catalyzed Hydrocarboxylation: Mechanistic Analysis Reveals Unusual Transition State for Carbon-Carbon Bond Formation. doi: 10.1021/acs.organomet.7b00899;
♦ ACS Catalysis 2017, 7231. Enantioselective Incorporation of CO₂: Status and Potential. UiT´s open research archive;